DOCSLIB.ORG

The Pharmacologist 2 0 0 8 March

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Pharmacologist 2 0 0 8 March Vol. 50 Number 1 The Pharmacologist 2 0 0 8 March Happy Birthday ASPET!!! th 100 Anniversary Celebration Details Inside: Don’t Miss the ASPET Centennial Meeting At Experimental Biology 2008 April 5-9, 2008, San Diego Featuring: Exciting Opening Reception: DJ, Food, Drinks and more Special Centennial Symposia: Exciting topics from each division Centennial Store: Selling ASPET merchandise for the first time ever ASPET Birthday Party: A Street Festival in the Gaslamp District ASPET Student Fiesta: Band, Food, and Drinks Nobel Laureate Reception: For Students to meet Nobel Laureates Great Giveaways: Luggage Tags, Pins, Posters, Compendiums Abel Number Lounge: Look up your Abel Number Plus Much More!! Also Inside this Issue: ASPET Election Results ASPET Award Winners 2008 EB 2008 Program Grid Special Executive Officer Interview Abstracts from the Great Lakes Chapter and Southeastern Chapter Meetings A Publication of the American Society for 1 Pharmacology and Experimental Therapeutics - ASPET Volume 50 Number 1, 2008 The Pharmacologist is published and distributed by the American Society for Pharmacology and Experimental Therapeutics. The PHARMACOLOGIST Editor Suzie Thompson EDITORIAL ADVISORY BOARD News Bryan F. Cox, Ph.D. Ronald N. Hines, Ph.D. Terrence J. Monks, Ph.D. Election Results . page 3 COUNCIL Award Winners for 2008. page 4 President Kenneth P. Minneman, Ph.D. EB 2008 Program Grid . page 12 President-Elect ASPET Centennial Update . page 17 Joe A. Beavo, Ph.D. Past President Special Centennial Feature: The View From the Elaine Sanders-Bush, Ph.D. Executive Office . page 21 Secretary/Treasurer Annette E. Fleckenstein, Ph.D. Special Lecture: The Origin and Development of Secretary/Treasurer-Elect Behavioral Pharmacology . page 26 Susan G. Amara, Ph.D. Past Secretary/Treasurer Lynn Wecker, Ph.D. Features Councilors Bryan F. Cox, Ph.D. John S. Lazo, Ph.D. Terrence J. Monks, Ph.D. Journals . page 34 Chair, Board of Publications Trustees Public Affairs & Government Relations . page 35 James E. Barrett, Ph.D. Chair, Program Committee Division News . page 36 Jack Bergman, Ph.D. Chapter News Chair, Long Range Planning Committee Elaine Sanders-Bush, Ph.D. Great Lakes Chapter Abstracts . page 38 Executive Officer Southeastern Chapter Summary & Abstracts . page 47 Christine K. Carrico, Ph.D. Members in the News. page 73 The Pharmacologist (ISSN 0031-7004) Staff News . page 73 is published quarterly in March, June, September, and December by the New ASPET Members . page 74 American Society for Pharmacology and In Sympathy . page 79 Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20814- 3995. Annual subscription rates: $20.00 for ASPET Members; $45.00 for Announcements U.S. nonmembers and institutions; $70.00 for nonmembers and institutions outside the U.S. Single copy: $20.00. Graduate Training Opportunities . page 80 Copyright © 2008 by the American Membership Information . page 83 Society for Pharmacology and Experimental Therapeutics, Inc. All Membership Application . page 84 rights reserved. Periodicals postage paid at Bethesda, MD. GST number for Canadian subscribers: BN:13489 2330 RT. Reminder: ASPET assumes no responsibility for the statements and opinions advanced Keep your membership up-to-date. You by contributors to The Pharmacologist. can now view your membership Deadlines for submission of material for publication: Issue 1, March 1; Issue 2, June 1; Issue 3, September 1; and Issue account details, update address 4, December 1. information, and pay your dues online Postmaster: Send address changes to: The Pharmacologist, ASPET, 9650 at www.aspet.org. Rockville Pike, Bethesda, MD 20814- 3995. A Publication of the American Society for 2 Pharmacology and Experimental Therapeutics - ASPET Volume 50 Number 1, 2008 ELECTION 2008 RESULTS President-Elect Brian M. Cox, Professor of Pharmacology and Neurosciences at Uniformed Services University of the Health Sciences, will assume the duty and responsibilities of President- Elect of ASPET in July 2008. Dr. Cox has been a member of ASPET since 1976. He served as the Chair of the Board of Publications Trustees from 2002–2007 and has served on the Editorial Boards of the Journal of Pharmacology and Experimental Therapeutics (1998-present), Molecular Pharmacology (1981-1994), and Molecular Interventions (2000-2002). Dr. Cox was a member of the ASPET Scientific Program Committee from 1986–1990 and chaired the Program Committee from 1990-1996. He served as ASPET’s representative to the Experimental Biology Program Committee from 1991-1994 and to the Experimental Biology Board from 1996-1999. He chaired the EB Board from 1998-1999. Dr. Cox also chaired the IUPHAR 2002 Scientific Program Committee. He has served as Secretary/Treasurer of ASPET (1997-1999) and has been a member of Council since 1990 (ex officio as Program and BPT Chair and voting as Secretary/Treasurer). Dr. Cox has also served as the ASPET representative to the 1998 IUPHAR Congress International Advisory Committee. Secretary/Treasurer-Elect David R. Sibley, Chief of the Section on Molecular Neuropharmacology at National Institute of Neurological Disorders and Stroke, National Institutes of Health, will assume the role of Secretary/Treasurer-Elect in July 2008. Dr. Sibley has been a member of ASPET since 1985. He has been a member of the Scientific Program Committee since 2005 and serves as the Chair of the Julius Axelrod Award Committee. He was a member of the ASPET Nominating Committee in 2003 and a member of the Scientific Council from 2005-2007. Dr. Sibley has been a member of the Executive Committee of the Division for Neuropharmacology since 2001, having been elected to the position of Secretary/Treasurer in 2002 and Chair in 2005 for a two-year term. He is a member of the Editorial Boards of the Journal of Pharmacology and Experimental Therapeutics (2004-present) and Molecular Pharmacology (2006-present). Dr. Sibley has organized and chaired several symposia for the ASPET annual meeting. Councilor Suzanne G. Laychock, Professor of Pharmacology and Toxicology and Senior Associate Dean for Research and Biomedical Education, Facilities Planning Officer of the State University of New York at Buffalo School of Medicine and Biomedical Sciences, will assume the position of Councilor in July 2008. Dr. Laychock has been a member of ASPET since 1983. She has been an at-large member of the Scientific Program Committee since 2004 and has served on the Centennial Committee since its inception. She was a member of the Subcommittee on Women in Pharmacology from 1988 to 1991 and chaired the Committee on Women in Pharmacology from 1996 to 1999, while concurrently serving on the Committee on Professional Affairs. Dr. Laychock was elected to the Nominating Committee in 2001. From 2001 to 2004 she served on the John J. Abel Award Committee. She served as ASPET’s representative to FASEB’s Excellence in Science Committee from 1999 to 2002. She was a member of the Editorial Advisory Board for the Journal of Pharmacology and Experimental Therapeutics from 1988 to 1991. A Publication of the American Society for 3 Pharmacology and Experimental Therapeutics - ASPET Volume 50 Number 1, 2008 AWARD WINNERS FOR 2008 Randy D. Blakely, PhD ` ASPET-Julius Axelrod Award Randy D. Blakely, Ph.D., Allan D. Bass Professor of Pharmacology in the Vanderbilt University School of Medicine and Director of the Vanderbilt Center for Molecular Neuroscience, is the recipient of the 2008 ASPET Julius Axelrod Award. The Award is given to recognize outstanding scientific contributions in research and mentoring. The Julius Axelrod Award in Pharmacology was established to honor the memory of the eminent American pharmacologist who shaped the fields of neuroscience, drug metabolism and biochemistry. From 1991 through 2006, the Julius Axelrod Award was presented by the Catecholomine Club. Dr. Blakely pursued undergraduate studies at Emory University prior to earning his Ph.D. in Neuroscience at the Johns Hopkins University School of Medicine. He pursued postdoctoral studies within the HHMI Center for Molecular Neuroscience at Yale University. Dr. Blakely has made fundamental discoveries impacting pharmacology and neuroscience, introduced new techniques and approaches to the field of transporter biology, and has enhanced our appreciation for regulatory mechanisms that dictate synaptic function and drug action. Dr. Blakely is perhaps best known for his pioneering work identifying human genes encoding norepinephrine, serotonin and choline transporters. His more recent work has identified sites of cocaine and antidepressant recognition, has discovered multiple transporter regulatory pathways, and has elucidated contributions of transporter genetic variation to human disorders. Dr. Blakely’s research has embraced multiple model systems from C. elegans to transgenic mice to human platelets in a quest to capture the power of different approaches for an understanding of transporter physiology, drug recognition and regulation. Dr. Blakely has mentored numerous young pharmacologists and neuroscientists throughout his career and has served as Director of both graduate and postdoctoral training programs at Vanderbilt. He is the current Director of the Vanderbilt Postdoctoral Training Program in Neurogenomics and the Vanderbilt/NIMH Silvio O.Conte Center for Neuroscience Research. Katerina Akassoglou, PhD John J. Abel Award Katerina Akassoglou, Ph.D., Assistant Professor of Pharmacology at the University of California at San Diego, is the recipient of the 2008 John
Load more

Recommended publications
  • Nicotinic Stimulation Produces Multiple Forms of Increased Glutamatergic Synaptic Transmission
    The Journal of Neuroscience, September 15, 1998, 18(18):7075–7083 Nicotinic Stimulation Produces Multiple Forms of Increased Glutamatergic Synaptic Transmission Kristofer A. Radcliffe and John A. Dani Division of Neuroscience, Baylor College of Medicine, Houston, Texas 77030-3498 Synaptic modulation and long-term synaptic changes are initiate calcium-dependent mechanisms that are known to in- thought to be the cellular correlates for learning and memory duce glutamatergic synaptic plasticity. The results with evoked (Madison et al., 1991; Aiba et al., 1994; Goda and Stevens, synaptic currents showed that nAChR activity can alter the 1996). The hippocampus is a center for learning and memory relationship between the incoming presynaptic activity and that receives abundant cholinergic innervation and has a high outgoing postsynaptic signaling along glutamatergic fibers. density of nicotinic acetylcholine receptors (nAChRs) (Wada et Thus, the same information arriving along the same glutama- al., 1989; Woolf, 1991). We report that strong, brief stimulation tergic afferents will be processed differently when properly of nAChRs enhanced hippocampal glutamatergic synaptic timed nicotinic activity converges onto the glutamatergic pre- transmission on two independent time scales and altered the synaptic terminals. Influencing information processing at gluta- relationship between consecutively evoked synaptic currents. matergic synapses may be one way in which nicotinic cholin- The nicotinic synaptic enhancement required extracellular cal- ergic activity influences cognitive processes. Disruption of cium and was produced by the activation of presynaptic a7- these nicotinic cholinergic mechanisms may contribute to the containing nAChRs. Although one form of glutamatergic en- deficits associated with the degeneration of cholinergic func- hancement lasted only for seconds, another form lasted for tions during Alzheimer’s disease.
    [Show full text]
  • Neuronal Nicotinic Receptors: from Structure to Pathology
    Progress in Neurobiology 74 (2004) 363–396 www.elsevier.com/locate/pneurobio Neuronal nicotinic receptors: from structure to pathology C. Gotti, F. Clementi* CNR, Institute of Neuroscience, Cellular and Molecular Pharmacology Section, Department of Medical Pharmacology and Center of Excellence on Neurodegenerative Diseases, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy Received 22 July 2004; accepted 29 September 2004 Available online 27 October 2004 Abstract Neuronal nicotinic receptors (NAChRs) form a heterogeneous family of ion channels that are differently expressed in many regions of the central nervous system (CNS) and peripheral nervous system. These different receptor subtypes, which have characteristic pharmacological and biophysical properties, have a pentameric structure consisting of the homomeric or heteromeric combination of 12 different subunits (a2–a10, b2–b4). By responding to the endogenous neurotransmitter acetylcholine, NAChRs contribute to a wide range of brain activities and influence a number of physiological functions. Furthermore, it is becoming evident that the perturbation of cholinergic nicotinic neurotransmission can lead to various diseases involving nAChR dysfunction during development, adulthood and ageing. In recent years, it has been discovered that NAChRs are present in a number of non-neuronal cells where they play a significant functional role and are the pathogenetic targets in several diseases. NAChRs are also the target of natural ligands and toxins including nicotine (Nic), the most widespread drug of abuse. This review will attempt to survey the major achievements reached in the study of the structure and function of NAChRs by examining their regional and cellular localisation and the molecular basis of their functional diversity mainly in pharmacological and biochemical terms.
    [Show full text]
  • Iberiotoxin-Induced Block of Kca Channels Induces Dihydropyridine
    JPET Fast Forward. Published on January 24, 2003 as DOI: 10.1124/jpet.102.046102 JPET FastThis articleForward. has not Published been copyedited on and January formatted. 24,The final2003 version as DOI:10.1124/jpet.102.046102 may differ from this version. JPET/2002/46102 Iberiotoxin-induced Block of KCa Channels Induces Dihydropyridine Sensitivity of ACh Release from Mammalian Motor Nerve Terminals Downloaded from Michael T. Flink and William D. Atchison Department of Pharmacology & Toxicology jpet.aspetjournals.org Michigan State University E. Lansing, MI 48824 Address all correspondence including reprint requests to: at ASPET Journals on September 23, 2021 Dr. Bill Atchison Dept. Pharmacology & Toxicology Michigan State University B-331 Life Sciences Bldg. East Lansing, MI 48824-1317 Phone: (517) 353-4947 Fax: (517) 432-1341 Email: [email protected] 1 Copyright 2003 by the American Society for Pharmacology and Experimental Therapeutics. JPET Fast Forward. Published on January 24, 2003 as DOI: 10.1124/jpet.102.046102 This article has not been copyedited and formatted. The final version may differ from this version. JPET/2002/46102 Running Title: KCa Channel Block and DHP-sensitivity of ACh Release at NMJ (59 spaces) Document Statistics: Text Pages: 15 Tables: 1 Figures: 5 References: 42 Downloaded from Abstract: 249 words Introduction: 760 words Discussion: 1241 jpet.aspetjournals.org at ASPET Journals on September 23, 2021 LIST OF ABBREVIATIONS: ACh, acetylcholine; BSA, bovine serum albumin; Cav, voltage-activated calcium channel; DAP, 3,4 diaminopyridine; DHP, dihydropyridine;EPP, end-plate potential; HEPES, N-2- hydroxyethylpiperazine-N-2-ethanesulfonic acid ; KCa, calcium-activated potassium; MEPP, miniature end-plate potential 2 JPET Fast Forward.
    [Show full text]
  • Prefrontal Α7nachr Signaling Differentially Modulates Afferent
    Research Articles: Systems/Circuits Prefrontal α7nAChR signaling differentially modulates afferent drive and trace fear conditioning behavior in adolescent and adult rats https://doi.org/10.1523/JNEUROSCI.1941-20.2020 Cite as: J. Neurosci 2021; 10.1523/JNEUROSCI.1941-20.2020 Received: 27 July 2020 Revised: 29 November 2020 Accepted: 23 December 2020 This Early Release article has been peer-reviewed and accepted, but has not been through the composition and copyediting processes. The final version may differ slightly in style or formatting and will contain links to any extended data. Alerts: Sign up at www.jneurosci.org/alerts to receive customized email alerts when the fully formatted version of this article is published. Copyright © 2021 the authors 1 Prefrontal α7nAChR signaling differentially modulates afferent drive 2 and trace fear conditioning behavior in adolescent and adult rats 3 4 5 6 7 Running title: Prefrontal α7nAChR control of afferent drive 8 9 10 11 Anabel M. M. Miguelez Fernandez, Hanna M. Molla, Daniel R. Thomases, and Kuei Y. Tseng* 12 13 Department of Anatomy and Cell Biology, University of Illinois at Chicago, IL 14 15 16 17 *Corresponding Author: Kuei Y. Tseng, MD, PhD 18 Department of Anatomy and Cell Biology 19 University of Illinois at Chicago – College of Medicine 20 Chicago, IL 60612, USA 21 Email: [email protected] 22 23 24 Number of figures: 8 25 Number of tables: 0 26 Abstract: 250 27 Main text: 4,030 words (Introduction: 451; Methods: 1,205; Results: 979; Discussion: 1,395) 28 29 30 31 32 Acknowledgements 33 Supported by NIH Grants R01-MH086507 and R01-MH105488 to KYT, and UIC College of Medicine 34 funds to KYT.
    [Show full text]
  • Nicotine Induces Polyspermy in Sea Urchin Eggs Through a Non-Cholinergic Pathway Modulating Actin Dynamics
    cells Article Nicotine Induces Polyspermy in Sea Urchin Eggs through a Non-Cholinergic Pathway Modulating Actin Dynamics 1,2 1, 2 1, Nunzia Limatola , Filip Vasilev y, Luigia Santella and Jong Tai Chun * 1 Department of Biology and Evolution of Marine Organisms, Stazione Zoologica Anton Dohrn, I-80121 Napoli, Italy; [email protected] (N.L.); [email protected] (F.V.) 2 Department of Research Infrastructures for Marine Biological Resources, Stazione Zoologica Anton Dohrn, I-80121 Napoli, Italy; [email protected] * Correspondence: [email protected] Current address: Centre de Recherche du Centre Hospitalier de l’Université de Montreal (CRCHUM) y Montreal, QC H2X 0A9, Canada. Received: 8 November 2019; Accepted: 21 December 2019; Published: 25 December 2019 Abstract: While alkaloids often exert unique pharmacological effects on animal cells, exposure of sea urchin eggs to nicotine causes polyspermy at fertilization in a dose-dependent manner. Here, we studied molecular mechanisms underlying the phenomenon. Although nicotine is an agonist of ionotropic acetylcholine receptors, we found that nicotine-induced polyspermy was neither mimicked by acetylcholine and carbachol nor inhibited by specific antagonists of nicotinic acetylcholine receptors. Unlike acetylcholine and carbachol, nicotine uniquely induced drastic rearrangement of egg cortical microfilaments in a dose-dependent way. Such cytoskeletal changes appeared to render the eggs more receptive to sperm, as judged by the significant alleviation of polyspermy by latrunculin-A and mycalolide-B. In addition, our fluorimetric assay provided the first evidence that nicotine directly accelerates polymerization kinetics of G-actin and attenuates depolymerization of preassembled F-actin. Furthermore, nicotine inhibited cofilin-induced disassembly of F-actin.
    [Show full text]
  • Alkaloids Pp. 178-End.Pdf
    Hydrastine Found in the roots and rhizomes of Hydrastis canadensis (family: Ranunculaceae). Uses: To control uterine hemorrhage. Traditional use of this root as: 1. Tonic {a medicine that strengthens). Abusamra Yousef Dr. 2. Uterine hemorrhage. 3. Catarrhal conditions. 178 Berberine: Berberies species) and)البرباريسية From Berberidaceae . .(Hydrastis)الفصيلة ال َح ْوذانية Ranunculaceae . Used as antiemetic, antibacterial and anti-inflammatory. Also, it is used for liver diseases. Sanguinarine: blood) دموية From the roots of Sanguinaria canadensis . Dr. Yousef Abusamra Yousef Dr. root) {Family Papaveraceae}. Native to America. Its effect resembles colchicine, i.e. causes doubling of chromosomes number (polyploidy). 179 . Used for atonic dyspepsia with hepatic symptoms. عسر الهضم Jatrorrhizine A protoberberine Benefits: alkaloid Antifungal, antibacterial, Antidiabetic, antiinflammatory. Dr. Yousef Abusamra Yousef Dr. Berberine 180 A quaternary amine alkaloid. Hydrastine Curare alkaloids: Bis-benzylisoquinoline. obtained from the bark and stems of Chondrodendrum tomentosum (family: Menispermaceae). The name is derived from “urari”; an Indian word indicating “poison”. The term “curare” is used to indicate the crude extract prepared from different species. Abusamra Yousef Dr. Was used by certain natives of the Amazon regions of South America as arrow poison. Some of these extracts were poisonous by virtue of a convulsant action and 181 others by paralyzing action (Most remarkable). Mechanism of action of d-tubocurarine Dr. Yousef Abusamra Yousef Dr. 182 • Curare possesses: 1. A paralyzing effect on voluntary muscles. 2. A toxic effect on blood vessels. 3. A histamine–like effect. Most of the activity is attributed to d-tubocurarine. Uses: 1- In surgical anesthesia, as it produces muscular relaxation without deep anesthesia.
    [Show full text]
  • Differing Time Dependencies of Object Recognition Memory Impairments Produced by Nicotinic and Muscarinic Cholinergic Antagonism in Perirhinal Cortex
    Downloaded from learnmem.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press Research Differing time dependencies of object recognition memory impairments produced by nicotinic and muscarinic cholinergic antagonism in perirhinal cortex Chris J. Tinsley,1,3 Nadine S. Fontaine-Palmer,1 Maria Vincent,1 Emma P.E. Endean,1 John P. Aggleton,2 Malcolm W. Brown,1 and E. Clea Warburton1 1MRC Centre for Synaptic Plasticity, School of Physiological Sciences, Bristol University, Bristol BS8 1TD, United Kingdom; 2School of Psychology, Cardiff University, Cardiff CF10 3AT, United Kingdom The roles of muscarinic and nicotinic cholinergic receptors in perirhinal cortex in object recognition memory were com- pared. Rats’ discrimination of a novel object preference test (NOP) test was measured after either systemic or local infusion into the perirhinal cortex of the nicotinic receptor antagonist methyllycaconitine (MLA), which targets alpha-7 (a7) amongst other nicotinic receptors or the muscarinic receptor antagonists scopolamine, AFDX-384, and pirenzepine. Methyllycaconitine administered systemically or intraperirhinally before acquisition impaired recognition memory tested after a 24-h, but not a 20-min delay. In contrast, all three muscarinic antagonists produced a similar, unusual pattern of impairment with amnesia after a 20-min delay, but remembrance after a 24-h delay. Thus, the amnesic effects of nicotinic and muscarinic antagonism were doubly dissociated across the 20-min and 24-h delays. The same pattern of shorter-term but not longer-term memory impairment was found for scopolamine whether the object preference test was carried out in a square arena or a Y-maze and whether rats of the Dark Agouti or Lister-hooded strains were used.
    [Show full text]
  • Neuronal Nicotinic Receptors
    NEURONAL NICOTINIC RECEPTORS Dr Christopher G V Sharples and preparations lend themselves to physiological and pharmacological investigations, and there followed a Professor Susan Wonnacott period of intense study of the properties of nAChR- mediating transmission at these sites. nAChRs at the Department of Biology and Biochemistry, muscle endplate and in sympathetic ganglia could be University of Bath, Bath BA2 7AY, UK distinguished by their respective preferences for C10 and C6 polymethylene bistrimethylammonium Susan Wonnacott is Professor of compounds, notably decamethonium and Neuroscience and Christopher Sharples is a hexamethonium,5 providing the first hint of diversity post-doctoral research officer within the among nAChRs. Department of Biology and Biochemistry at Biochemical approaches to elucidate the structure the University of Bath. Their research and function of the nAChR protein in the 1970’s were focuses on understanding the molecular and facilitated by the abundance of nicotinic synapses cellular events underlying the effects of akin to the muscle endplate, in electric organs of the acute and chronic nicotinic receptor electric ray,Torpedo , and eel, Electrophorus . High stimulation. This is with the goal of affinity snakea -toxins, principallyaa -bungarotoxin ( - Bgt), enabled the nAChR protein to be purified, and elucidating the structure, function and subsequently resolved into 4 different subunits regulation of neuronal nicotinic receptors. designateda ,bg , and d .6 An additional subunit, e , was subsequently identified in adult muscle. In the early 1980’s, these subunits were cloned and sequenced, The nicotinic acetylcholine receptor (nAChR) arguably and the era of the molecular analysis of the nAChR has the longest history of experimental study of any commenced.
    [Show full text]
  • Bioactive Marine Drugs and Marine Biomaterials for Brain Diseases
    Mar. Drugs 2014, 12, 2539-2589; doi:10.3390/md12052539 OPEN ACCESS marine drugs ISSN 1660–3397 www.mdpi.com/journal/marinedrugs Review Bioactive Marine Drugs and Marine Biomaterials for Brain Diseases Clara Grosso 1, Patrícia Valentão 1, Federico Ferreres 2 and Paula B. Andrade 1,* 1 REQUIMTE/Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, no. 228, 4050-313 Porto, Portugal; E-Mails: [email protected] (C.G.); [email protected] (P.V.) 2 Research Group on Quality, Safety and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS (CSIC), P.O. Box 164, Campus University Espinardo, Murcia 30100, Spain; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +351-22042-8654; Fax: +351-22609-3390. Received: 30 January 2014; in revised form: 10 April 2014 / Accepted: 16 April 2014 / Published: 2 May 2014 Abstract: Marine invertebrates produce a plethora of bioactive compounds, which serve as inspiration for marine biotechnology, particularly in drug discovery programs and biomaterials development. This review aims to summarize the potential of drugs derived from marine invertebrates in the field of neuroscience. Therefore, some examples of neuroprotective drugs and neurotoxins will be discussed. Their role in neuroscience research and development of new therapies targeting the central nervous system will be addressed, with particular focus on neuroinflammation and neurodegeneration. In addition, the neuronal growth promoted by marine drugs, as well as the recent advances in neural tissue engineering, will be highlighted. Keywords: aragonite; conotoxins; neurodegeneration; neuroinflammation; Aβ peptide; tau hyperphosphorylation; protein kinases; receptors; voltage-dependent ion channels; cyclooxygenases Mar.
    [Show full text]
  • Nociceptive Thresholds Are Controlled Through Spinal ОІ2-Subunit
    PAINÒ 152 (2011) 2131–2137 www.elsevier.com/locate/pain Nociceptive thresholds are controlled through spinal b2-subunit-containing nicotinic acetylcholine receptors Ipek Yalcin a, Alexandre Charlet a,b, Matilde Cordero-Erausquin a, Luc-Henri Tessier a, Marina R. Picciotto c, ⇑ Rémy Schlichter a,b, Pierrick Poisbeau a,b, Marie-José Freund-Mercier a,b, Michel Barrot a, a Institut des Neurosciences Cellulaires et Intégratives, Centre National de la Recherche Scientifique, Strasbourg, France b Faculté des Sciences de la Vie, Université de Strasbourg, Strasbourg, France c Division of Molecular Psychiatry, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Yale University School of Medicine, New Haven, CT, USA Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. article info abstract Article history: Although cholinergic drugs are known to modulate nociception, the role of endogenous acetylcholine in Received 13 October 2010 nociceptive processing remains unclear. In the current study, we evaluated the role of cholinergic trans- Received in revised form 8 April 2011 mission through spinal b2-subunit-containing nicotinic acetylcholine receptors in the control of nocicep- Accepted 8 May 2011 tive thresholds. We show that mechanical and thermal nociceptive thresholds are significantly lowered ⁄ ⁄ in b2 -knockout (KO) mice. Using nicotinic antagonists in these mice, we demonstrate that b2 -nAChRs are responsible for tonic inhibitory control of mechanical thresholds at the spinal level. We further Keywords: hypothesized that tonic b ⁄-nAChR control of mechanical nociceptive thresholds might implicate GAB- Nicotinic 2 Aergic transmission since spinal nAChR stimulation can enhance inhibitory transmission. Indeed, the b -nAChRs 2 ⁄ Acetylcholine GABAA receptor antagonist bicuculline decreased the mechanical threshold in wild-type but not b2 -KO ⁄ ⁄ GABA mice, and the agonist muscimol restored basal mechanical threshold in b2 -KO mice.
    [Show full text]
  • Fungi.Mycotoxins.Pdf
    Fungi: Mycotoxin: Acremonium crotocinigenum Crotocin Aspergillus favus Alfatoxin B, cyclopiazonic acid Aspergillus fumigatus Fumagilin, gliotoxin Aspergillus carneus Critrinin Aspergillus clavatus Cytochalasin, patulin Aspergillus Parasiticus Alfatoxin B Aspergillus nomius Alfatoxin B Aspergillus niger Ochratoxin A, malformin, oxalicacid Aspergillus nidulans Sterigmatocystin Aspergillus ochraceus Ochratoxin A, penicillic acid Aspergillus versicolor Sterigmatocystin, 5 ethoxysterigmatocystin Aspergillus ustus Ausdiol, austamide, austocystin, brevianamide Aspergillus terreus Citreoviridin Alternaria Alternariol, altertoxin, altenuene, altenusin, tenuazonic acid Arthrinium Nitropropionic acid Bioploaris Cytochalasin, sporidesmin, sterigmatocystin Chaetomium Chaetoglobosin A,B,C. Sterigmatocystin Cladosporium Cladosporic acid Clavipes purpurea Ergotism Cylindrocorpon Trichothecene Diplodia Diplodiatoxin Fusarium Trichothecene, zearalenone Fusarium moniliforme Fumonisins Emericella nidulans Sterigmatocystin Gliocladium Gliotoxin Memnoniella Griseofulvin, dechlorogriseofulvin, epidecholorgriseofulvin, trichodermin, trichodermol Myrothecium Trichothecene Paecilomyces Patulin, viriditoxin Penicillium aurantiocandidum Penicillic acid Penicillium aurantiogriseum Penicillic acid Penicillium brasalianum Penicillic acid Penicillium brevicompactum Mycophenolic acid Penicillium camemberti Cyclopiazonic acid Penicillium carneum Mycophenolic acid, Roquefortine C Penicillium crateriforme Rubratoxin Penicillium citrinum Citrinin Penicillium commune Cyclopiazonic
    [Show full text]
  • Eosinophil Functions Mitogen-Activated Protein Kinase In
    The Differential Role of Extracellular Signal-Regulated Kinases and p38 Mitogen-Activated Protein Kinase in Eosinophil Functions This information is current as of September 30, 2021. Tetsuya Adachi, Barun K. Choudhury, Susan Stafford, Sanjiv Sur and Rafeul Alam J Immunol 2000; 165:2198-2204; ; doi: 10.4049/jimmunol.165.4.2198 http://www.jimmunol.org/content/165/4/2198 Downloaded from References This article cites 57 articles, 38 of which you can access for free at: http://www.jimmunol.org/content/165/4/2198.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 30, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2000 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Differential Role of Extracellular Signal-Regulated Kinases and p38 Mitogen-Activated Protein Kinase in Eosinophil Functions1 Tetsuya Adachi, Barun K. Choudhury, Susan Stafford, Sanjiv Sur, and Rafeul Alam2 The activation of eosinophils by cytokines is a major event in the pathogenesis of allergic diseases.
    [Show full text]